You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯港股聚焦(06.02)︱碧桂園5月實現權益合同銷售573.8億元;BC科技集團與渣打合力推出數字資產交易平台
格隆匯 06-02 23:15

【業績預吿】

華盛國際控股(01323.HK)預計年度轉虧為盈逾3800萬港元

香港信貸(01273.HK)年度純利預增不低於25%

東方報業集團(00018.HK):預計年度純利不少於2億港元

偉工控股(01793.HK)年度純利預減62.2%

【運營數據】

碧桂園(02007.HK)5月實現權益合同銷售573.8億元

融信中國(03301.HK)5月銷售額達139.45億元

力高集團(01622.HK)首5月實現合約銷售178.22億元

中國奧園(03883.HK)5月實現物業合同銷售115.1億元 同比增長12%

恆騰網絡(00136.HK):南瓜電影APP 5月新增註冊會員654.66萬人

景瑞控股(01862.HK)5月簽約銷售額達29.03億元

【增減持】

福祿控股(02101.HK)獲董事長符熙增持181.05萬股 未來或將進一步增持股份

天津創業環保股份(01065.HK):獲股東百思樂斯貿易一致行動人累計增持1476.6萬股H股

築友智造科技(00726.HK)獲董事會主席劉衞星增持155萬股

【併購出售】

文化傳信(00343.HK)擬6300萬港元收購仿腦科技(深圳)全部股份

【增發供股】

愛帝宮(00286.HK)擬配售不超1.9億股 最多籌1.178億港元

【投資運營】

BC科技集團(00863.HK)與渣打合作建立機構數字資產交易平台

中國有色礦業(01258.HK)附屬與卡莫阿銅礦簽訂銅精礦來料加工協議

遠大醫藥(00512.HK):TLX591-CDx在日本完成首例患者給藥及TLX591在澳洲獲批開展III期臨牀研究

大唐發電(00991.HK)與大唐集團擬向大唐核電增資2.156億元

新濠國際發展(00200.HK):新濠博亞娛樂董事會已批准5億美元股份購回計劃

中國生物製藥(01177.HK)旗下抗菌藥"利奈唑胺葡萄糖注射液"獲通過一致性評價

李氏大藥廠(00950.HK)合作公司Dilafor已完成Tafoxiparin的2b期研究

【回購註銷】

爪哇控股(00251.HK)6月2日耗資5112.83萬港元回購620萬股

歡喜傳媒(01003.HK)6月2日耗資828.42萬港元回購429萬股

天鴿互動(01980.HK)6月2日耗資262.05萬港元回購184.3萬股

朗生醫藥(00503.HK)6月2日耗資222.6萬港元回購100萬股

安德利果汁(02218.HK):累計耗資138.8萬港元回購20.5萬股H股

安德利果汁(02218.HK)6月2日耗資138.8萬港元回購20.5萬股

【股權激勵】

華津國際控股(02738.HK)授出2527.27萬份購股權

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account